ANNEX II, Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refu…

In forcesince 29 Oct 2009

Application — Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference

Article 14(1)(b) health claim referring to children’s development and health | Lactoral | Lactoral helps to bring back the normal functioning of the alimentary tract during its microflora disturbances (for example in case of loose stools, after taking antibiotics, in case of intestinal disorders caused by enteric pathogens) | EFSA-Q-2008-269

Article 14(1)(b) health claim referring to children’s development and health | Lactoral | Lactoral is recommended in order to improve the general immunity by maintaining the microbiological balance | EFSA-Q-2008-477

Article 14(1)(b) health claim referring to children’s development and health | Lactoral | Lactoral helps to protect the alimentary system against enteric pathogens because of strong antagonistic properties and helps to build the natural intestinal barrier | EFSA-Q-2008-478

Article 14(1)(b) health claim referring to children’s development and health | Lactoral | Lactoral helps to maintain natural intestinal microflora during travel, changing the climatic zone or a diet, especially in poor hygiene conditions | EFSA-Q-2008-479

Article 14(1)(b) health claim referring to children’s development and health | Lactoral | Lactoral contains living probiotic bacteria with strong ability to intestinal tract colonisation, isolated from healthy, naturally fed infant | EFSA-Q-2008-480

Article 14(1)(b) health claim referring to children’s development and health | Mumomega® | Mumomega® provides the nourishments that support healthy central nervous system development | EFSA-Q-2008-328

Article 14(1)(b) health claim referring to children’s development and health | Efalex® | Efalex® may help maintain coordination | EFSA-Q-2008-121

Article 14(1)(b) health claim referring to children’s development and health | Efalex® | Efalex® may help maintain concentration | EFSA-Q-2008-317

Article 14(1)(b) health claim referring to children’s development and health | Efalex® | Efalex® may help maintain and support brain development and function | EFSA-Q-2008-318

Article 14(1)(b) health claim referring to children’s development and health | Efalex® | Efalex® may help maintain learning ability | EFSA-Q-2008-319

Article 14(1)(b) health claim referring to children’s development and health | Efalex® | Efalex® may help maintain and support eye development and function | EFSA-Q-2008-320

Article 14(1)(b) health claim referring to children’s development and health | Eye q baby® | Eye q baby® provides the nourishments that support healthy central nervous system development | EFSA-Q-2008-119

Article 14(1)(b) health claim referring to children’s development and health | Eye q® | Eye q® provides the nourishments that help children to maintain healthy brain functions | EFSA-Q-2008-329

Article 14(1)(b) health claim referring to children’s development and health | Eye q® | Eye q® provides the nourishments that help children to maintain concentration levels | EFSA-Q-2008-330